Perspectives from those who live it every day.
Dr Bill Nelson and Dr Elizabeth Jaffee discuss the creation of Break Through Cancer, a new collaborative partnership between The Johns Hopkins Kimmel Cancer Center, The Dana Farber Cancer Institute, The Koch Institute for Integrative Cancer Research at MIT, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center that will help accelerate research, clinical […]
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body. They propose that therapies targeting this process could be developed to halt or prevent metastasis and reduce breast cancer deaths. Natural killer (NK) […]
In our next podcast, Dr Bill Nelson speaks with Kimmel Cancer Center Deputy Director, Dr Elizabeth Jaffee, to review her year as President of the American Association for Cancer Research and to assess the progress being made in the use of immune therapy to treat pancreatic cancer. In this preview, Dr Jaffee looks ahead to […]
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]
Dr Bill Nelson, the Director of the Kimmel Cancer Center at Johns Hopkins, begins a new podcast series focused on cancer treatment and research. In episode one, Dr Nelson speaks with Dr Elizabeth Jaffee, the Kimmel Cancer Center’s Deputy Director and the Associate Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, from the annual meeting […]